HYBRID EVENT: Join us in person in Boston, Massachusetts, USA or attend virtually from anywhere.
October 22-24, 2026 | Boston, Massachusetts, USA
PHE 2026

Artificial radionuclides and evolutionary mismatch: Vulnerability of the colon, pancreas, diabetes, and arteries

Speaker at Public Health Conferences - Sebastiano Venturi
Department of Public Health of Rimini, Italy
Title : Artificial radionuclides and evolutionary mismatch: Vulnerability of the colon, pancreas, diabetes, and arteries

Abstract:

The global dissemination of artificial radionuclides since 1945 represents a novel environmental condition in evolutionary terms. Isotopes such as Cesium-137 (Cs-137) and Iodine-131 (I-131), generated through nuclear weapons testing, reactor accidents, and nuclear energy production, were not present during the evolutionary history of terrestrial life. The new radio-iodine decays into inert Xenon, while carbon-14 decays into nitrogen-14 via beta emission; this transformation occurs at the atomic level and does not directly disrupt established macromolecular carbon frameworks, although local molecular damage may occur during decay events. This paper suggests an evolutionary hypothesis that chronic internal exposure to such radionuclides may constitute an underexplored factor in long-term metabolic, pancreatic, colon and arterial disorders. The framework integrates evolutionary biology, ion mimicry theory, oxidative stress mechanisms, and internal dosimetry. It further addresses an ongoing scientific disagreement regarding the adequacy of prevailing low-dose radiation risk models, particularly with respect to non-cancer metabolic endpoints. While no causal association between environmental Cs-137 exposure and arteries, diabetes, pancreatic or colorectal cancer is currently recognized by major international health authorities, this position paper of CCPDA-hypothesis, supports that targeted interdisciplinary investigation is warranted.

Biography:

Sebastiano Venturi, studied Iodine and iodine deficiency disorders and the extrathyroidal antioxidant action of iodine in human organisms. He reported the first articles on the association of iodine and stomach, colon, breast and salivary glands cancer, presented in Beijing and London Congresses. He also published the first study on evolutionary aspect of iodine in primitive living cells. In 2020-25 he studied the first correlation on Cesium-137 and its correlation on Colon and Pancreatic Cancers, Pancreatitis & Diabetes that reported at St. Petersburg (2022) and Singapore (2025) International Congresses, through also an experimental form with Artificial Intelligence (A.I.).

Youtube
Watsapp